Torthaí cuardaigh - Amanda Mikels‐Vigdal

  • 1 - 5 toradh as 5 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal

    Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal de réir Naoki Ikenaga, Zhenwei Peng, Kahini A. Vaid, Susan B. Liu, Shuhei Yoshida, Deanna Sverdlov, Amanda Mikels‐Vigdal, Victoria Smith, Detlef Schuppan, Yury Popov

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Wnt signaling and Loxl2 promote aggressive osteosarcoma

    Wnt signaling and Loxl2 promote aggressive osteosarcoma de réir Kazuhiko Matsuoka, Latifa Bakiri, Lena I. Wolff, Markus Linder, Amanda Mikels‐Vigdal, Ana Patiño‐García, Fernando Lecanda, Christine Hartmann, Maria Sibilia, Erwin F. Wagner

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors

    MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors de réir Vladi Juric, Chris O’Sullivan, Erin Stefanutti, Maria Kovalenko, Andrew E. Greenstein, Vivian Barry-Hamilton, Igor Mikaelian, Jeremiah D. Degenhardt, Yue Peng, Victoria Smith, Amanda Mikels‐Vigdal

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer

    Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer de réir Derek Marshall, Susan K. Lyman, Scott McCauley, Maria Kovalenko, Rhyannon Spangler, Chian Liu, Michael Lee, Christopher O’Sullivan, Vivian Barry-Hamilton, Haben Ghermazien, Amanda Mikels‐Vigdal, Carlos García, Brett Jorgensen, Arleene C. Velayo, Ruth Wang, Joanne I. Adamkewicz, Victoria Smith

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment

    Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment de réir Jin Yang, Konstantinos Savvatis, Jong Seok Kang, Peidong Fan, Hongyan Zhong, Karen Schwartz, Vivian Barry, Amanda Mikels‐Vigdal, Serge Karpinski, Dmytro Kornyeyev, Joanne I. Adamkewicz, Xuhui Feng, Qiong Zhou, Ching Shang, Praveen Kumar, Dillon Phan, Mario Kašner, Begoña López, Javier Dı́ez, Keith Wright, R. Kovacs, Peng‐Sheng Chen, Thomas Quertermous, Victoria Smith, Lina Yao, Carsten Tschöpe, Ching-Pin Chang

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: